{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:28:42Z","timestamp":1772760522849,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deutsche ForschungsgemeinschaftDeutsche Forschungsgemeinschaft (DFG, German Research Foundation)","award":["RO3577\/3-2"],"award-info":[{"award-number":["RO3577\/3-2"]}]},{"name":"Deutsche ForschungsgemeinschaftDeutsche Forschungsgemeinschaft (DFG, German Research Foundation)","award":["GRK1739\/2"],"award-info":[{"award-number":["GRK1739\/2"]}]},{"name":"Hiege Foundation"},{"name":"Monika-Kutzner Foundation"},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"crossref","award":["DKH-111886"],"award-info":[{"award-number":["DKH-111886"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"crossref","award":["DKH-70112257"],"award-info":[{"award-number":["DKH-70112257"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejca.2018.12.024","type":"journal-article","created":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T10:56:53Z","timestamp":1549105013000},"page":"137-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma"],"prefix":"10.1016","volume":"109","author":[{"given":"B.","family":"Shannan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Matschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chauvistr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rauschenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Utikal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Forschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Berking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Terheyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dabrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gutzmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rafei-Shamsabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Meiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Heinzerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Livingstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e1ta","family":"V\u00e1raljai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hoewner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Klode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Scheffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marchetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sannino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.G.P.","family":"Gr\u00fcnewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3524-7858","authenticated-orcid":false,"given":"D.","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Jendrossek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Roesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2018.12.024_bib1","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","article-title":"Melanoma","volume":"1","author":"Schadendorf","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ejca.2018.12.024_bib2","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1038\/onc.2014.249","article-title":"Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma","volume":"34","author":"Roesch","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2018.12.024_bib3","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bjc.2017.142","article-title":"Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases","volume":"116","author":"Parakh","year":"2017","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejca.2018.12.024_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000475715","article-title":"Outcomes in melanoma patients treated with BRAF\/MEK-Directed therapy or immune checkpoint inhibition stratified by clinical trial versus standard of care","volume":"93","author":"Goldman","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2018.12.024_bib5","first-page":"228","article-title":"Combination controversies: checkpoint inhibition alone or in combination for the treatment of melanoma?","volume":"32","author":"Warner","year":"2018","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ejca.2018.12.024_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ctrv.2017.01.006","article-title":"Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: a network meta-analysis","volume":"54","author":"Pasquali","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2018.12.024_bib7","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cncr.30594","article-title":"Molecular insights into melanoma brain metastases","volume":"123","author":"Westphal","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2018.12.024_bib8","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.2147\/OTT.S119428","article-title":"BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy","volume":"9","author":"Chowdhary","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ejca.2018.12.024_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejca.2017.01.007","article-title":"Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies","volume":"75","author":"Choong","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2018.12.024_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/14737140.2017.1296764","article-title":"Radiosurgery\/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases","volume":"17","author":"Trino","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejca.2018.12.024_bib11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2015.07.061","article-title":"Non-genomic and immune evolution of melanoma acquiring MAPKi resistance","volume":"162","author":"Hugo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2018.12.024_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/2159-8290.CD-17-0682","article-title":"Exploiting drug addiction mechanisms to select against MAPKi-resistant melanoma","volume":"8","author":"Hong","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejca.2018.12.024_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","article-title":"The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejca.2018.12.024_bib14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","article-title":"Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma","volume":"24","author":"Gide","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2018.12.024_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","article-title":"A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth","volume":"141","author":"Roesch","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2018.12.024_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2018.12.024_bib17","doi-asserted-by":"crossref","first-page":"12723","DOI":"10.18632\/oncotarget.3713","article-title":"JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN\/AKT signaling in hepatocellular carcinoma cells","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2018.12.024_bib18","doi-asserted-by":"crossref","first-page":"18226","DOI":"10.1073\/pnas.1317577110","article-title":"Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma","volume":"110","author":"Yuan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2018.12.024_bib19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.celrep.2018.09.081","article-title":"Jumonji inhibitors overcome radioresistance in cancer through changes in H3K4 methylation at double-strand breaks","volume":"25","author":"Bayo","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ejca.2018.12.024_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/ars.2015.6589","article-title":"Targeted inhibition of glutamine-dependent glutathione metabolism overcomes death resistance induced by chronic cycling hypoxia","volume":"25","author":"Matschke","year":"2016","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.ejca.2018.12.024_bib21","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1038\/sj.onc.1206682","article-title":"DNA damage checkpoint control in cells exposed to ionizing radiation","volume":"22","author":"Iliakis","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2018.12.024_bib22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/sj.cdd.4400874","article-title":"ATM, a central controller of cellular responses to DNA damage","volume":"8","author":"Khanna","year":"2001","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ejca.2018.12.024_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2307\/3578111","article-title":"Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc","volume":"125","author":"McKenna","year":"1991","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejca.2018.12.024_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature20123","article-title":"Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma","volume":"539","author":"Tirosh","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2018.12.024_bib25","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1073\/pnas.1119836109","article-title":"H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence","volume":"109","author":"Chicas","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2018.12.024_bib26","first-page":"w14183","article-title":"Data mining the cancer genome Atlas in the era of precision cancer medicine","volume":"145","author":"Cheng","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ejca.2018.12.024_bib27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2018.12.024_bib28","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2018.12.024_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2018.12.024_bib30","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/sj.jid.5700324","article-title":"Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells","volume":"126","author":"Roesch","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2018.12.024_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/fon.15.297","article-title":"Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilities","volume":"12","author":"Zahnreich","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.ejca.2018.12.024_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2015.06.026","article-title":"Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence","volume":"117","author":"Schick","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2018.12.024_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.radonc.2010.12.017","article-title":"Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032","volume":"98","author":"Sambade","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2018.12.024_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2015.07.003","article-title":"Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma","volume":"368","author":"Lin","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2018.12.024_bib35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.12.024_bib36","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1158\/0008-5472.CAN-15-3377","article-title":"JARID1B enables transit between distinct states of the stem-like cell population in oral cancers","volume":"76","author":"Facompre","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2018.12.024_bib37","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1128\/MCB.00128-08","article-title":"The histone demethylase KDM5b\/JARID1b plays a role in cell fate decisions by blocking terminal differentiation","volume":"28","author":"Dey","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ejca.2018.12.024_bib38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2007.03.001","article-title":"PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation","volume":"25","author":"Yamane","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejca.2018.12.024_bib39","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1128\/MCB.02180-06","article-title":"Demethylation of histone H3K36 and H3K9 by Rph1: a vestige of an H3K9 methylation system in Saccharomyces cerevisiae?","volume":"27","author":"Klose","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ejca.2018.12.024_bib40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cell.2007.02.003","article-title":"RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3","volume":"128","author":"Christensen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2018.12.024_bib41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2007.02.017","article-title":"The X-linked mental retardation gene SMCX\/JARID1C defines a family of histone H3 lysine 4 demethylases","volume":"128","author":"Iwase","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2018.12.024_bib42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature19362","article-title":"Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos","volume":"537","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2018.12.024_bib43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1073\/pnas.90.2.393","article-title":"Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB","volume":"90","author":"Forsberg","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2018.12.024_bib44","first-page":"1873","article-title":"Adenovirus infection enhances killing of melanoma cells by a mitotoxin","volume":"57","author":"Satyamoorthy","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2018.12.024_bib45","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4161\/cc.8.3.7701","article-title":"Single-vector inducible lentiviral RNAi system for oncology target validation","volume":"8","author":"Wiederschain","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejca.2018.12.024_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-148X.2008.00527.x","article-title":"Cracking the system: melanoma complexity demands new therapeutic approaches","volume":"22","author":"Vultur","year":"2009","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919300012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919300012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T16:56:44Z","timestamp":1556729804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919300012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":46,"alternative-id":["S0959804919300012"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.12.024","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}